Endocrinology, Vol 136, 2464-2469, Copyright © 1995 by Endocrine Society

ARTICLES

Insulin inhibits nuclear phosphatase activity: requirement for the C- terminal domain of the insulin receptor

JE Reusch, P Hsieh, P Bhuripanyo, K Carel, JW Leitner, JM Olefsky and B Draznin
Medical Research Service, Veterans Affairs Medical Center, Denver, Colorado 80220, USA.

Insulin's interaction with its receptor initiates a multitude of cellular effects on metabolism, growth, and differentiation. We recently described an insulin-mediated inhibition of nuclear protein phosphatase 2A (PP-2A), which is associated with an increase in phosphorylation of the transcription factor cAMP response element- binding protein. To clarify the role of nuclear PP-2A inhibition in the insulin signaling cascade, we examined the regulation of this phosphatase activity by insulin in Rat-1 fibroblasts overexpressing normal (HIRc) or mutant human insulin receptors (delta CT cells, deletion of a 43-amino acid C-terminal domain). The delta CT cells represent an excellent model of impaired metabolic and intact mitogenic action of insulin. Insulin inhibited nuclear PP-2A activity and enhanced cAMP response element-binding protein phosphorylation in HIRc cells, but not in delta CT cells. The delta CT cells exhibited normal ras activation and blunted mitogen-activating protein kinase phosphorylation and activation in response to insulin (16-fold in HIRc cells vs. 3-fold in delta CT cells), indicating that the mitogen- activating protein kinase pathway is important for the regulation of nuclear PP-2A activity by insulin. We conclude that insulin inhibits nuclear PP-2A activity, and that the carboxy-terminal domain of the insulin receptor is important for this effect.

This article has been cited by other articles:

				P. Soni, M. Lakkis, M. N. Poy, M. A. Fernström, and S. M. Najjar The Differential Effects of pp120 (Ceacam 1) on the Mitogenic Action of Insulin and Insulin-Like Growth Factor 1 Are Regulated by the Nonconserved Tyrosine 1316 in the Insulin Receptor Mol. Cell. Biol., June 1, 2000; 20(11): 3896 - 3905. [Abstract] [Full Text]

				J. E. B. Reusch, L. A. Colton, and D. J. Klemm CREB Activation Induces Adipogenesis in 3T3-L1 Cells Mol. Cell. Biol., February 1, 2000; 20(3): 1008 - 1020. [Abstract] [Full Text]

				N. Gletsu, W. Dixon, and M. T. Clandinin Insulin Receptor at the Mouse Hepatocyte Nucleus after a Glucose Meal Induces Dephosphorylation of a 30-kDa Transcription Factor and a Concomitant Increase in Malic Enzyme Gene Expression J. Nutr., December 1, 1999; 129(12): 2154 - 2161. [Abstract] [Full Text]

				D. J. Klemm, W. J. Roesler, T. Boras, L. A. Colton, K. Felder, and J. E-B. Reusch Insulin Stimulates cAMP-response Element Binding Protein Activity in HepG2 and 3T3-L1 Cell Lines J. Biol. Chem., January 9, 1998; 273(2): 917 - 923. [Abstract] [Full Text] [PDF]

				H. Hansen, U. Svensson, J. Zhu, L. Laviola, F. Giorgino, G. Wolf, R. J. Smith, and H. Riedel Interaction between the Grb10 SH2 Domain and the Insulin Receptor Carboxyl Terminus J. Biol. Chem., April 12, 1996; 271(15): 8882 - 8886. [Abstract] [Full Text] [PDF]